NASDAQ · PCSA
Processa Pharmaceuticals, Inc.
Healthcare · Biotechnology
$1.89
Up+$0.00 (+0.00%)
Updated Nov 2, 2026, 6:47 AM
SID Score
4.7/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 15.65M
- P/E ratio
- -1.01
- Dividend yield
- 0.00%
- 52-week range
- $1.04 – $3.45
- Volume
- 25.37K
- Avg. volume
- 9.87M
Price performance · PCSA
PCSA price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 30, 2026
PCSA closed at $1.89 after 20 trading sessions, up 26.85% for the selected period.
- Last close
- $1.89
- Period change
- +26.85%
- Period low
- $1.35
- Period high
- $1.90
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | $1.81 | $1.9394 | $1.81 | $1.89 | 25.37K |
| Oct 29, 2026 | $1.84 | $2.10 | $1.80 | $1.89 | 104.81K |
| Oct 28, 2026 | $1.75 | $1.94 | $1.75 | $1.85 | 24.08K |
| Oct 27, 2026 | $1.76 | $1.87 | $1.7061 | $1.82 | 13.38K |
| Oct 26, 2026 | $1.78 | $1.85 | $1.7207 | $1.795 | 19.53K |
| Oct 23, 2026 | $1.7611 | $1.90 | $1.7506 | $1.81 | 35.05K |
| Oct 22, 2026 | $1.71 | $1.8894 | $1.71 | $1.86 | 16.14K |
| Oct 21, 2026 | $1.79 | $1.79 | $1.68 | $1.76 | 11.66K |
| Oct 20, 2026 | $1.73 | $1.79 | $1.59 | $1.79 | 18.25K |
| Oct 19, 2026 | $1.74 | $1.74 | $1.6901 | $1.73 | 19.68K |
| Oct 16, 2026 | $1.69 | $1.75 | $1.61 | $1.69 | 22.06K |
| Oct 15, 2026 | $1.58 | $1.72 | $1.5301 | $1.68 | 31.15K |
| Oct 14, 2026 | $1.75 | $1.75 | $1.56 | $1.615 | 46.37K |
| Oct 13, 2026 | $1.93 | $1.93 | $1.77 | $1.77 | 69.18K |
| Oct 12, 2026 | $1.56 | $1.98 | $1.50 | $1.90 | 441.03K |
| Oct 9, 2026 | $1.32 | $1.87 | $1.041 | $1.52 | 2.97M |
| Oct 8, 2026 | $1.42 | $1.43 | $1.32 | $1.35 | 12.8K |
| Oct 7, 2026 | $1.53 | $1.53 | $1.41 | $1.42 | 12.9K |
| Oct 6, 2026 | $1.51 | $1.59 | $1.45 | $1.52 | 18.59K |
| Oct 5, 2026 | $1.56 | $1.63 | $1.49 | $1.49 | 25.74K |
Latest PCSA news
The latest Smart Investors Daily articles mentioning PCSA.
Stock researchMarket Activity · Sentiment
Company
Market Activity
Research & News

